Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Fever and Papular-purpuric Exanthema in a 7-year-old Boy.

Arias-Vivas E, Illán-Ramos M, Campos L, Pérez-Rodríguez O, Culebras E, Ramos-Amador JT.

Pediatr Infect Dis J. 2019 Dec;38(12):1254. doi: 10.1097/INF.0000000000002465. No abstract available.

PMID:
31738346
2.

Analysis of the impact of diagnostic virology tests on the use of antibiotics in paediatric inpatients with community-acquired pneumonia.

Aguilera-Alonso D, Illán-Ramos M, Daoud Z, Guinea V, Culebras E, Ramos JT.

Enferm Infecc Microbiol Clin. 2019 Oct 24. pii: S0213-005X(19)30233-2. doi: 10.1016/j.eimc.2019.08.008. [Epub ahead of print] English, Spanish.

PMID:
31668863
3.
4.

A culture medium for screening 16S rRNA methylase-producing pan-aminoglycoside resistant Gram-negative bacteria.

Nordmann P, Mazé A, Culebras E, Dobias J, Jayol A, Poirel L.

Diagn Microbiol Infect Dis. 2018 Jun;91(2):118-122. doi: 10.1016/j.diagmicrobio.2018.01.026. Epub 2018 Feb 3.

PMID:
29496380
5.

In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents.

López Díaz MC, Ríos E, Rodríguez-Avial I, Simaluiza RJ, Picazo JJ, Culebras E.

Int J Antimicrob Agents. 2017 Aug;50(2):191-196. doi: 10.1016/j.ijantimicag.2017.01.039. Epub 2017 May 31.

PMID:
28577932
6.

Characterization and circulation of seasonal influenza viruses in Madrid, 2010-2016.

Chiarella FC, Daoud Z, Fuentes-Ferrer ME, Ramos Amador JT, Picazo JJ, Culebras E.

J Med Virol. 2017 Oct;89(10):1726-1733. doi: 10.1002/jmv.24857. Epub 2017 Jun 6.

PMID:
28504416
7.

Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes.

López-Diaz MD, Culebras E, Rodríguez-Avial I, Rios E, Viñuela-Prieto JM, Picazo JJ, Rodríguez-Avial C.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02454-16. doi: 10.1128/AAC.02454-16. Print 2017 Feb.

8.

Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae.

Ríos E, López MC, Rodríguez-Avial I, Culebras E, Picazo JJ.

J Med Microbiol. 2017 Feb;66(2):169-174. doi: 10.1099/jmm.0.000399. Epub 2017 Mar 7.

PMID:
27902381
9.

[Studies of bacterial typing with MALDI-TOF].

Culebras E, Alvarez-Buylla A, Jose Artacho Reinoso M, Antonio Lepe J.

Enferm Infecc Microbiol Clin. 2016 Jun;34 Suppl 2:42-6. doi: 10.1016/S0213-005X(16)30190-2. Review. Spanish.

PMID:
27389292
10.

Evaluation of the Alere i Influenza A&B assay for rapid identification of influenza A and influenza B viruses.

Chiarella FC, Culebras E, Fuentes-Ferrer ME, Picazo JJ.

J Med Microbiol. 2016 Jun;65(6):456-61. doi: 10.1099/jmm.0.000249. Epub 2016 Mar 11.

PMID:
26967368
11.

In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.

Rodríguez-Avial I, Pena I, Picazo JJ, Rodríguez-Avial C, Culebras E.

Int J Antimicrob Agents. 2015 Dec;46(6):616-21. doi: 10.1016/j.ijantimicag.2015.07.021. Epub 2015 Sep 9.

PMID:
26391381
12.

Correction: Crystal Structure of Hcp from Acinetobacter baumannii: A Component of the Type VI Secretion System.

Ruiz FM, Santillana E, Spínola-Amilibia M, Torreira E, Culebras E, Romero A.

PLoS One. 2015 Aug 26;10(8):e0136978. doi: 10.1371/journal.pone.0136978. eCollection 2015. No abstract available.

13.

Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?

García-Salguero C, Rodríguez-Avial I, Picazo JJ, Culebras E.

Antimicrob Agents Chemother. 2015 Oct;59(10):5959-66. doi: 10.1128/AAC.00873-15. Epub 2015 Jul 13.

14.

Crystal Structure of Hcp from Acinetobacter baumannii: A Component of the Type VI Secretion System.

Ruiz FM, Santillana E, Spínola-Amilibia M, Torreira E, Culebras E, Romero A.

PLoS One. 2015 Jun 16;10(6):e0129691. doi: 10.1371/journal.pone.0129691. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0136978.

15.

Incidence of pediatric invasive pneumococcal disease in the Island of Majorca (2008-2010), an area with non-universal vaccination, and estimations of serotype & children population coverage by available conjugate vaccines.

Picazo J, Dueñas J, Ramirez A, Perez AR, Padilla E, Herrero S, Gallegos C, Culebras E, Balseiro C, Mendez C.

BMC Infect Dis. 2013 Oct 29;13:503. doi: 10.1186/1471-2334-13-503.

16.

Detection and genotyping of human respiratory viruses in clinical specimens from children with acute respiratory tract infections.

Culebras E, Betriu C, Vázquez-Cid E, López-Varela E, Rueda S, Picazo JJ.

Rev Esp Quimioter. 2013 Mar;26(1):47-50.

17.

Rapid diagnosis of invasive pneumococcal disease in pediatric population.

Picazo JJ, Contreras JR, Ríos E, Culebras E, Rodríguez-Avial I, Méndez C, Betriu C; Heracles Study Group.

J Microbiol Methods. 2013 May;93(2):116-20. doi: 10.1016/j.mimet.2013.03.001. Epub 2013 Mar 13.

PMID:
23499921
18.

Optimized method for Acinetobacter species carbapenemase detection and identification by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Álvarez-Buylla A, Picazo JJ, Culebras E.

J Clin Microbiol. 2013 May;51(5):1589-92. doi: 10.1128/JCM.00181-13. Epub 2013 Feb 27.

19.

Identification of Acinetobacter species: is Bruker biotyper MALDI-TOF mass spectrometry a good alternative to molecular techniques?

Alvarez-Buylla A, Culebras E, Picazo JJ.

Infect Genet Evol. 2012 Mar;12(2):345-9. doi: 10.1016/j.meegid.2012.01.002. Epub 2012 Jan 12.

PMID:
22266021
20.

Rapid identification of clinical isolates of Bacteroides species by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry.

Culebras E, Rodríguez-Avial I, Betriu C, Gómez M, Picazo JJ.

Anaerobe. 2012 Feb;18(1):163-5. doi: 10.1016/j.anaerobe.2011.09.005. Epub 2011 Sep 22.

PMID:
21963387
21.

In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci.

Rodríguez-Avial I, Culebras E, Betriu C, Morales G, Pena I, Picazo JJ.

J Antimicrob Chemother. 2012 Jan;67(1):167-9. doi: 10.1093/jac/dkr403. Epub 2011 Sep 27.

PMID:
21954458
22.

Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance.

Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, López-Fabal F, Gómez M; VIRA Study Group.

Diagn Microbiol Infect Dis. 2011 Jul;70(3):373-9. doi: 10.1016/j.diagmicrobio.2011.02.009.

PMID:
21683269
23.

[Methicillin-resistant Staphylococcus aureus: changes in the susceptibility pattern to daptomycin during a 10-year period (2001-2010)].

Picazo JJ, Betriu C, Culebras E, Rodríguez-Avial I, Gómez M, López-Fabal F; Grupo VIRA.

Rev Esp Quimioter. 2011 Jun;24(2):107-11. Spanish.

24.

[Clinical use of rapid assays for the detection of influenza An/H1N1].

Pérez J, Culebras E, Baos E, Alvarez-Buylla A, Rodríguez-Avial I, Candel FJ, Picazo JJ.

Rev Esp Quimioter. 2010 Dec;23(4):215-6. Spanish. No abstract available.

25.

High prevalence of viable Mycobacterium avium subspecies paratuberculosis in Crohn's disease.

Mendoza JL, San-Pedro A, Culebras E, Cíes R, Taxonera C, Lana R, Urcelay E, de la Torre F, Picazo JJ, Díaz-Rubio M.

World J Gastroenterol. 2010 Sep 28;16(36):4558-63.

26.
27.

Comparative in vitro activity of ceftobiprole against Gram-positive cocci.

Betriu C, Culebras E, Gómez M, López-Fabal F, Rodríguez-Avial I, Picazo JJ.

Int J Antimicrob Agents. 2010 Aug;36(2):111-3. doi: 10.1016/j.ijantimicag.2010.04.003.

PMID:
20554163
28.

Outbreak of Acinetobacter baumannii producing OXA-66 in a Spanish hospital: epidemiology and study of patient movements.

Culebras E, González-Romo F, Head J, Gómez M, Morales G, Picazo JJ.

Microb Drug Resist. 2010 Dec;16(4):309-15. doi: 10.1089/mdr.2009.0113. Epub 2010 Jun 7.

PMID:
20528099
29.

Activity of doripenem against extended-spectrum beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates.

Betriu C, Gómez M, López-Fabal F, Culebras E, Rodríguez-Avial I, Picazo JJ.

Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1179-81. doi: 10.1007/s10096-010-0974-3. Epub 2010 Jun 4.

PMID:
20521156
30.

Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.

Betriu C, Morales G, Rodríguez-Avial I, Culebras E, Gómez M, López-Fabal F, Picazo JJ.

Antimicrob Agents Chemother. 2010 May;54(5):2212-5. doi: 10.1128/AAC.01653-09. Epub 2010 Feb 22.

31.

Direct serogrouping of Streptococcus pneumoniae strains in clinical samples by use of a latex agglutination test.

Sanz JC, Culebras E, Ríos E, Rodríguez-Avial I, Wilhelmi I, Ramos B, Ordobás M, Picazo JJ.

J Clin Microbiol. 2010 Feb;48(2):593-5. doi: 10.1128/JCM.01651-09. Epub 2009 Dec 9.

32.

Activity of daptomycin against staphylococci collected from bloodstream infections in Spanish medical centers.

Picazo JJ, Betriu C, Culebras E, Rodríguez-Avial I, Gómez M, López F; VIRA Study Group.

Diagn Microbiol Infect Dis. 2009 Aug;64(4):448-51. doi: 10.1016/j.diagmicrobio.2009.03.020.

PMID:
19631100
33.

[Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].

Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, López F, Gómez M; Grupo VIRA.

Enferm Infecc Microbiol Clin. 2010 Jan;28(1):13-6. doi: 10.1016/j.eimc.2008.09.012. Epub 2009 May 5. Spanish.

PMID:
19406529
34.

[In vitro activities of colistin combinations against Pseudomonas aeruginosa isolated from the intensive care unit].

López-Fabal F, Culebras E, Bonilla I, Gómez M, Picazo JJ.

Rev Esp Quimioter. 2008 Sep;21(3):189-93. Spanish.

35.

Antimicrobial susceptibility and macrolide resistance genes in Enterococcus faecium with reduced susceptibility to quinupristin-dalfopristin: level of quinupristin-dalfopristin resistance is not dependent on erm(B) attenuator region sequence.

López F, Culebras E, Betriú C, Rodríguez-Avial I, Gómez M, Picazo JJ.

Diagn Microbiol Infect Dis. 2010 Jan;66(1):73-7. doi: 10.1016/j.diagmicrobio.2008.06.004. Epub 2008 Jul 23.

PMID:
18653303
36.

Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.

Betriu C, Culebras E, Gómez M, López F, Rodríguez-Avial I, Picazo JJ.

Antimicrob Agents Chemother. 2008 Jul;52(7):2686-90. doi: 10.1128/AAC.00081-08. Epub 2008 May 12.

37.

Fluoroquinolone resistance among invasive viridans group streptococci and Streptococcus bovis isolated in Spain.

Rodríguez-Avial I, Rodríguez-Avial C, Culebras E, Picazo JJ.

Int J Antimicrob Agents. 2007 Apr;29(4):478-80. Epub 2007 Feb 12. No abstract available.

PMID:
17296288
38.

[Antimicrobial resistance surveillance: VIRA STUDY 2006].

Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, Gómez M, López F; Grupo VIRA.

Enferm Infecc Microbiol Clin. 2006 Dec;24(10):617-28. Spanish.

PMID:
17194387
39.

Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study.

Betriu C, Rodríguez-Avial I, Gómez M, Culebras E, López F, Alvarez J, Picazo JJ; Spanish Tigecycline Group.

Diagn Microbiol Infect Dis. 2006 Dec;56(4):437-44. Epub 2006 Sep 1.

PMID:
16949245
40.

Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins.

Betriu C, Salso S, Sánchez A, Culebras E, Gómez M, Rodríguez-Avial I, Picazo JJ.

Int J Antimicrob Agents. 2006 Jul;28(1):1-5. Epub 2006 Jun 12.

PMID:
16769202
41.

In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates.

Rodríguez-Avial I, Rodríguez-Avial C, López O, Culebras E, Picazo JJ.

Int J Antimicrob Agents. 2006 Apr;27(4):303-6. Epub 2006 Mar 15.

PMID:
16540293
42.

Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002).

Betriu C, Rodríguez-Avial I, Gómez M, Culebras E, Picazo JJ.

Diagn Microbiol Infect Dis. 2005 Nov;53(3):221-3. Epub 2005 Oct 21.

PMID:
16243476
43.

Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae.

Culebras E, Rodríguez-Avial I, Betriu C, Picazo JJ.

J Antimicrob Chemother. 2005 Nov;56(5):836-40. Epub 2005 Sep 26.

PMID:
16186169
44.

In vitro activity of tigecycline against Bacteroides species.

Betriu C, Culebras E, Gómez M, Rodríguez-Avial I, Picazo JJ.

J Antimicrob Chemother. 2005 Aug;56(2):349-52. Epub 2005 Jun 10.

PMID:
15951353
45.

In vitro activity of tigecycline against ampicillin-resistant Haemophilus influenzae isolates.

Betriu C, Gómez M, Rodríguez-Avial I, Culebras E, Picazo JJ.

J Antimicrob Chemother. 2005 May;55(5):809-10. Epub 2005 Mar 24. No abstract available.

PMID:
15790670
46.

[Carbapenem resistance determined by metalloenzymes in clinical isolates of Pseudomonas aeruginosa].

Sánchez A, Salso S, Culebras E, Picazo JJ.

Rev Esp Quimioter. 2004 Dec;17(4):336-40. Spanish.

47.
48.

Significance of nested PCR and quantitative real time PCR for cytomegalovirus detection in renal transplant recipients.

Kanaan A, Cour I, Alvarez-Lafuente R, Benedicto M, Culebras E, Prats D, Fernández C, Picazo JJ.

Int J Antimicrob Agents. 2004 Nov;24(5):455-62.

PMID:
15519477
49.

[Surveillance of antimicrobial resistance: VIRA study 2004].

Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, Gómez M; Grupo VIRA.

Enferm Infecc Microbiol Clin. 2004 Nov;22(9):517-25. Spanish.

PMID:
15511392
50.

In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance.

Betriu C, Culebras E, Rodríguez-Avial I, Gómez M, Sánchez BA, Picazo JJ.

Antimicrob Agents Chemother. 2004 Jan;48(1):323-5.

Supplemental Content

Loading ...
Support Center